Recent insights into the treatment of stable CAD: FFR-guided PCI vs. medical therapy

Herz

Volumn 38, Issue 4, 2013, Pages 376-381

  Van Nunen, L X ^a   Tonino, P A L ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

Coronary artery disease; Fractional flow reserve; Percutaneous coronary intervention; Prognosis; Revascularization

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; EXERCISE TEST; FRACTIONAL FLOW RESERVE; HUMAN; NON INVASIVE MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84879082891     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-013-3806-2     Document Type: Article

References (34)

1. The World Health Organization (2008) The top ten causes of death fact sheet
2. Ford ES, Ajani UA, Croft JB et al (2007) Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356:2388-2398
3. Abrams J (2005) Clinical practice. Chronic stable angina. N Engl J Med 352:2524-2533
4. Shah PK (2003) Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 41:15S-22S
5. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27:1341-1381
6. Shaw LJ, Berman DS, Maron DJ et al (2008) Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 117:1283-1291
7. Steg PG, James SK, Atar D et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569-2619
8. Hamm CW, Bassand JP, Agewall S et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999-3054
9. Katritsis DG, Ioannidis JP (2005) Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 111:2906-2912
10. Boden WE, O'Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503-1516
11. Frye RL, August P, Brooks MM et al (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503-2515
12. De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991-1001
13. Pijls NH, Sels JW (2012) Functional measurement of coronary stenosis. J Am Coll Cardiol 59:1045-1057
14. Tonino PA, De Bruyne B, Pijls NH et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360:213-224
15. Hachamovitch R, Berman DS, Shaw LJ et al (1998) Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97:535-543
16. Shaw LJ, Iskandrian AE (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11:171-185
17. Wijns W, Kolh P, Danchin N et al (2010) Guidelines on myocardial revascularization. Eur Heart J 31:2501-2555
18. Froelicher VF, Lehmann KG, Thomas R et al (1998) The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Veterans affairs cooperative study in health services #016 (QUEXTA) study group. Quantitative exercise testing and angiography. Ann Intern Med 128:965-974
19. Lima RS, Watson DD, Goode AR et al (2003) Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 42:64-70
20. Ragosta M, Bishop AH, Lipson LC et al (2007) Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease. Am J Cardiol 99:896-902
21. Lin GA, Dudley RA, Lucas FL et al (2008) Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA 300:1765-1773
22. Topol EJ, Nissen SE (1995) Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 92:2333-2342
23. Beauman GJ, Vogel RA (1990) Accuracy of individual and panel visual interpretations of coronary arteriograms: implications for clinical decisions. J Am Coll Cardiol 16:108-113
24. Brueren BR, Berg JM ten, Suttorp MJ et al (2002) How good are experienced cardiologists at predicting the hemodynamic severity of coronary stenoses when taking fractional flow reserve as the gold standard. Int J Cardiovasc Imaging 18:73-76
25. Pijls NH, Son JA van, Kirkeeide RL et al (1993) Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87:1354-1367
26. De Bruyne B, Pijls NH, Paulus WJ et al (1993) Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire. J Am Coll Cardiol 22:119-126
27. De Bruyne B, Baudhuin T, Melin JA et al (1994) Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 89:1013-1022
28. Pijls NH, De Bruyne B, Peels K et al (1996) Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334:1703-1708
29. Tonino PA, Fearon WF, De Bruyne B et al (2010) Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 55:2816-2821
30. Pijls NH, Schaardenburgh P van, Manoharan G et al (2007) Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 49:2105-2111
31. Bech GJ, De Bruyne B, Pijls NH et al (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103:2928-2934
32. Schomig A, Mehilli J, Waha A de et al (2008) A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 52:894-904
33. Hannan EL, Samadashvili Z, Cozzens K et al (2012) Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation 125:1870-1879
34. Hachamovitch R, Hayes SW, Friedman JD et al (2003) Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107:2900-2907